Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice
Crossref DOI link: https://doi.org/10.1007/s00277-015-2404-1
Published Online: 2015-06-28
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Becker, M.
Tschechne, B.
Reeb, M.
Schwinger, U.
Bruch, H.-R.
Frank, M.
Straßl, L.
License valid from 2015-06-28